pharma · T Cell Lymphoma · Diabetes Mellitus · CRSP
S.A
S.A.
S.A is a pharma organization headquartered in San Lorenzo, EU. It trades on NYSE under ticker CRSP. Primary therapeutic focus areas include T Cell Lymphoma, Diabetes Mellitus, Beta-Thalassemia, Sickle Cell Disease, B-cel
San Lorenzo, EU HQ
2011 Founded
50 Employees
Public company Type
CRSP · NYSE Ticker
Company details
- Status
- Public
- HQ
- San Lorenzo, EU
- Founded
- 2011
- Employees
- 50
- Programs
- 14
- Drugs
- 8
- Patents
- 65
CTX001
Phase 3 · mab · Sickle Cell Disease
CTX001 for Sickle Cell Disease is a Phase 3 program (mab) at S.A. with 2 ClinicalTrials.gov record(s).
Internal code VX21-CTX001-151
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- S.A.
- Phase
- Phase 3
- Modality
- mab
- Indication
- Sickle Cell Disease
- Status
- active
- Trials
- 2